Skip to content
Home/Companies/Biotech/Tobira Therapeutics

Tobira Therapeutics

Biotech·France·Exited 2016·Held 7yr
Entry
2009
Hold
7yr
Exit
2016

Who owns Tobira Therapeutics?

Tobira Therapeutics is a French Biotech company, now owned by Allergan, which acquired it in 2016 from Andera Partners.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 3 · 2009 · VC

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Buyer
Allergan
Exit Year
2016

More from BioDiscovery 3

Other portfolio companies in the same fund.

Cellnovo
Exited 2015
MedTechFrance· 2011
GenKyoTex
Exited 2014
BiotechFrance· 2011
Sapiens
Sapiens
Exited 2013
SaaSFrance· 2011
to Medtronic
Covagen
Exited 2014
BiotechFrance· 2010
to Johnson & Johnson
Parvulus Medical
Exited
MedTechFrance· 2010
Poxel
Poxel
Active
BiotechFrance· 2010

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Tobira Therapeutics?

Tobira Therapeutics is now owned by Allergan, which acquired it in 2016 from Andera Partners.

When did Allergan acquire Tobira Therapeutics?

Allergan acquired Tobira Therapeutics in 2016, buying from Andera Partners.

Who did Tobira Therapeutics sell to?

Andera Partners sold Tobira Therapeutics to Allergan in 2016 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue